Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryocompression for CIPN

NCT: NCT07064798 · RECRUITING

NCT IDNCT07064798
StatusRECRUITING
Start Date2025-10-22
Completion2027-08

Brief Summary

This study aims to evaluate the effectiveness, tolerability, and safety of using cooling therapy and pressure (cryocompression) to reduce peripheral neuropathy, a condition affecting the nerves supplying the arms and legs (limbs) resulting in possible numbness, pain, and/or loss of motor function, that may occur as a result of taxane-based chemotherapy. The name of the device used in this research study is: -Paxman Limb Cryocompression System (PLCS)

Frequently Asked Questions

What is Cryocompression for CIPN?

Cryocompression for CIPN is a clinical trial registered under NCT07064798. Current status: RECRUITING.

What is the status of NCT07064798?

The current status of NCT07064798 (Cryocompression for CIPN) is: RECRUITING.

When did Cryocompression for CIPN start?

Cryocompression for CIPN started on 2025-10-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.